Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Amit Roy

Showing results (81-90 of 288) with videos related to

Pageof 29
Sort By:
Journal of Pharmacokinetics and Pharmacodynamics|March 20, 2016
Model-based pharmacokinetic analysis of elotuzumab in patients with relapsed/refractory multiple myelomaLeonid Gibiansky, Chaitali Passey, Amit Roy, et al.
The Science of the Total Environment|June 18, 2013
Sustainable use of phosphorus: a finite resourceRoland W Scholz, Andrea E Ulrich, Marjatta Eilittä, et al.
BMC Biotechnology|October 23, 2013
Development of selectable marker free, insect resistant, transgenic mustard (Brassica juncea) plants using Cre/lox mediated recombinationArpita Bala, Amit Roy, Ayan Das, et al.
CPT: Pharmacometrics & Systems Pharmacology|July 24, 2019
Linking Tumor Growth Dynamics to Survival in Ipilimumab-Treated Patients With Advanced Melanoma Using Mixture Tumor Growth Dynamic ModelingYan Feng, Xiaoning Wang, Satyendra Suryawanshi, et al.
The New Phytologist|February 2, 2026
Engineering next-generation crops through CRISPR-mediated horizontal gene transferMadhab Kumar Sen, Amit Roy, Rajeev K Varshney, et al.
Frontiers in Microbiology|October 24, 2024
Comparative metagenomic study unveils new insights on bacterial communities in two pine-feeding <i>Ips</i> beetles (Coleoptera: Curculionidae: Scolytinae)Arunabha Khara, Amrita Chakraborty, Roman Modlinger, et al.
Clinical Pharmacology and Therapeutics|May 16, 2019
Nivolumab Clearance Is Stationary in Patients With Resected Melanoma on Adjuvant Therapy: Implications of Disease Status on Time-Varying ClearanceLora Hamuro, Paul Statkevich, Akintunde Bello, et al.
BMC Biotechnology|October 17, 2025
Retraction Note: Development of selectable marker free, insect resistant, transgenic mustard (Brassica juncea) plants using Cre/lox mediated recombinationArpita Bala, Amit Roy, Ayan Das, et al.
Cancer Chemotherapy and Pharmacology|February 11, 2016
Evaluation of the potential for QTc prolongation in patients with solid tumors receiving nivolumabShruti Agrawal, Ian Waxman, Alexandre Lambert, et al.
BMC Microbiology|October 28, 2015
Deciphering the mode of action of a mutant Allium sativum Leaf Agglutinin (mASAL), a potent antifungal protein on Rhizoctonia solaniPrithwi Ghosh, Amit Roy, Daniel Hess, et al.
Pageof 29

Showing results (81-90 of 288) with videos related to

Sort By:
Pageof 29
Journal of Pharmacokinetics and Pharmacodynamics|March 20, 2016
Model-based pharmacokinetic analysis of elotuzumab in patients with relapsed/refractory multiple myelomaLeonid Gibiansky, Chaitali Passey, Amit Roy, et al.
The Science of the Total Environment|June 18, 2013
Sustainable use of phosphorus: a finite resourceRoland W Scholz, Andrea E Ulrich, Marjatta Eilittä, et al.
BMC Biotechnology|October 23, 2013
Development of selectable marker free, insect resistant, transgenic mustard (Brassica juncea) plants using Cre/lox mediated recombinationArpita Bala, Amit Roy, Ayan Das, et al.
CPT: Pharmacometrics & Systems Pharmacology|July 24, 2019
Linking Tumor Growth Dynamics to Survival in Ipilimumab-Treated Patients With Advanced Melanoma Using Mixture Tumor Growth Dynamic ModelingYan Feng, Xiaoning Wang, Satyendra Suryawanshi, et al.
The New Phytologist|February 2, 2026
Engineering next-generation crops through CRISPR-mediated horizontal gene transferMadhab Kumar Sen, Amit Roy, Rajeev K Varshney, et al.
Frontiers in Microbiology|October 24, 2024
Comparative metagenomic study unveils new insights on bacterial communities in two pine-feeding <i>Ips</i> beetles (Coleoptera: Curculionidae: Scolytinae)Arunabha Khara, Amrita Chakraborty, Roman Modlinger, et al.
Clinical Pharmacology and Therapeutics|May 16, 2019
Nivolumab Clearance Is Stationary in Patients With Resected Melanoma on Adjuvant Therapy: Implications of Disease Status on Time-Varying ClearanceLora Hamuro, Paul Statkevich, Akintunde Bello, et al.
BMC Biotechnology|October 17, 2025
Retraction Note: Development of selectable marker free, insect resistant, transgenic mustard (Brassica juncea) plants using Cre/lox mediated recombinationArpita Bala, Amit Roy, Ayan Das, et al.
Cancer Chemotherapy and Pharmacology|February 11, 2016
Evaluation of the potential for QTc prolongation in patients with solid tumors receiving nivolumabShruti Agrawal, Ian Waxman, Alexandre Lambert, et al.
BMC Microbiology|October 28, 2015
Deciphering the mode of action of a mutant Allium sativum Leaf Agglutinin (mASAL), a potent antifungal protein on Rhizoctonia solaniPrithwi Ghosh, Amit Roy, Daniel Hess, et al.
Pageof 29